Latest Singapore Market News

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.

Macro Metals Limited has secured two non-binding letters of intent from licensed Singaporean importers for trial shipments of up to 600,000 cubic meters of sand from its Port Hedland deposit, marking a significant step in its export ambitions.

EZZ Life Science has inked a three-year distribution deal with ROFA Enterprises, marking a significant step into Southeast Asia’s booming health market. The agreement guarantees at least A$21 million in sales across Thailand, Vietnam, and Singapore.

Love Group Global Ltd posts a 4% rise in quarterly customer cash receipts, driven by strong growth in Singapore, while preparing to expand matchmaking services into the UK.